A detailed history of Prestige Wealth Management Group LLC transactions in Organon & Co. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 2,434 shares of OGN stock, worth $35,487. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,434
Previous 2,434 -0.0%
Holding current value
$35,487
Previous $50,000 8.0%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$17.45 - $21.96 $1,343 - $1,690
-77 Reduced 3.07%
2,434 $50,000
Q1 2024

Apr 26, 2024

SELL
$13.78 - $18.8 $165 - $225
-12 Reduced 0.48%
2,511 $47,000
Q4 2023

Apr 26, 2024

SELL
$10.95 - $17.32 $678 - $1,073
-62 Reduced 2.4%
2,523 $36,000
Q4 2023

Feb 08, 2024

SELL
$10.95 - $17.32 $678 - $1,073
-62 Reduced 2.4%
2,523 $36,000
Q3 2023

Apr 26, 2024

SELL
$16.59 - $23.77 $1,177 - $1,687
-71 Reduced 2.67%
2,585 $44,000
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $1,177 - $1,687
-71 Reduced 2.67%
2,585 $44,000
Q1 2023

Apr 26, 2024

BUY
$21.42 - $32.08 $3,105 - $4,651
145 Added 5.77%
2,656 $62,000
Q1 2023

May 16, 2023

SELL
$21.42 - $32.08 $192 - $288
-9 Reduced 0.34%
2,656 $62,000
Q4 2022

Feb 07, 2023

SELL
$23.31 - $28.61 $279 - $343
-12 Reduced 0.45%
2,665 $74,000
Q3 2022

Nov 01, 2022

SELL
$23.4 - $34.25 $421 - $616
-18 Reduced 0.67%
2,677 $62,000
Q2 2022

Aug 10, 2022

SELL
$31.66 - $38.9 $221 - $272
-7 Reduced 0.26%
2,695 $91,000
Q1 2022

May 05, 2022

SELL
$30.45 - $39.36 $1,918 - $2,479
-63 Reduced 2.28%
2,702 $94,000
Q4 2021

Feb 15, 2022

SELL
$28.67 - $37.13 $200 - $259
-7 Reduced 0.25%
2,765 $84,000
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $1,288 - $1,603
-45 Reduced 1.6%
2,772 $91,000
Q2 2021

Aug 12, 2021

BUY
$28.45 - $38.0 $80,143 - $107,046
2,817 New
2,817 $86,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.